| Dr Michael J Difrancesca, DPM | |
|
474 Conchester Hwy, Route 322, Aston, PA 19014-3129 | |
| (610) 485-8208 | |
| (610) 485-8254 |
| Full Name | Dr Michael J Difrancesca |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 21 Years |
| Location | 474 Conchester Hwy, Aston, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598711954 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213EP1101X | Podiatrist - Primary Podiatric Medicine | SC005831 (Pennsylvania) | Primary |
| Provider Name | Michael Difrancesca Podiatrist Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1003982497 PECOS PAC ID: 8729002217 Enrollment ID: O20060124000270 |
News Archive
Nearly 30 percent of U.S. adults with diabetes over the age of 40 are estimated to have diabetic retinopathy, with about 4 percent of this population having vision-threatening retinopathy, according to a study in the August 11 issue of JAMA.
Lawrence Gostin, JD, LLD (h.c.), Faculty Director of the O'Neill Institute for National and Global Health Law at Georgetown Law, was honored today for his "Lifetime Achievement in Public Health Law" by the American Public Health Association (APHA) Law Section. The award was presented in Chicago.
Coqui RadioPharmaceuticals Corp., a medical isotope company working to become the first U.S. commercial producer of Molybdenum-99 (Mo-99), is proud to announce it has formally signed a contract with INVAP to design its Medical Isotope Production Facility (MIPF) in Alachua, Fla. Mo-99 is the parent isotope of Technetium-99, which is used in 80 percent of nuclear medicine procedures worldwide.
A groundbreaking free tool to help oncologists choose the best therapies for patients with non-small-cell lung cancer has been launched this week by scientists at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland.
› Verified 5 days ago
| Provider Name | Foot & Ankle Associates Of Secane Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1891822037 PECOS PAC ID: 8022145192 Enrollment ID: O20100421000473 |
News Archive
Nearly 30 percent of U.S. adults with diabetes over the age of 40 are estimated to have diabetic retinopathy, with about 4 percent of this population having vision-threatening retinopathy, according to a study in the August 11 issue of JAMA.
Lawrence Gostin, JD, LLD (h.c.), Faculty Director of the O'Neill Institute for National and Global Health Law at Georgetown Law, was honored today for his "Lifetime Achievement in Public Health Law" by the American Public Health Association (APHA) Law Section. The award was presented in Chicago.
Coqui RadioPharmaceuticals Corp., a medical isotope company working to become the first U.S. commercial producer of Molybdenum-99 (Mo-99), is proud to announce it has formally signed a contract with INVAP to design its Medical Isotope Production Facility (MIPF) in Alachua, Fla. Mo-99 is the parent isotope of Technetium-99, which is used in 80 percent of nuclear medicine procedures worldwide.
A groundbreaking free tool to help oncologists choose the best therapies for patients with non-small-cell lung cancer has been launched this week by scientists at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael J Difrancesca, DPM 474 Conchester Hwy, Route 322, Aston, PA 19014-3129 Ph: (610) 485-8208 | Dr Michael J Difrancesca, DPM 474 Conchester Hwy, Route 322, Aston, PA 19014-3129 Ph: (610) 485-8208 |
News Archive
Nearly 30 percent of U.S. adults with diabetes over the age of 40 are estimated to have diabetic retinopathy, with about 4 percent of this population having vision-threatening retinopathy, according to a study in the August 11 issue of JAMA.
Lawrence Gostin, JD, LLD (h.c.), Faculty Director of the O'Neill Institute for National and Global Health Law at Georgetown Law, was honored today for his "Lifetime Achievement in Public Health Law" by the American Public Health Association (APHA) Law Section. The award was presented in Chicago.
Coqui RadioPharmaceuticals Corp., a medical isotope company working to become the first U.S. commercial producer of Molybdenum-99 (Mo-99), is proud to announce it has formally signed a contract with INVAP to design its Medical Isotope Production Facility (MIPF) in Alachua, Fla. Mo-99 is the parent isotope of Technetium-99, which is used in 80 percent of nuclear medicine procedures worldwide.
A groundbreaking free tool to help oncologists choose the best therapies for patients with non-small-cell lung cancer has been launched this week by scientists at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) in Geneva, Switzerland.
› Verified 5 days ago
Aston Foot Center Podiatrist Medicare: Medicare Enrolled Practice Location: 474 Conchester Hwy, Route 322, Aston, PA 19014 Phone: 610-485-8208 Fax: 610-485-8254 |